Hypofractionated Stereotactic Radiotherapy (HypoFXSRT) for Stage I Non-small Cell Lung Cancer: Updated Results of 257 Patients in a Japanese Multi-institutional Study
Top Cited Papers
- 31 July 2007
- journal article
- Published by Elsevier BV in Journal of Thoracic Oncology
- Vol. 2 (7), S94-S100
- https://doi.org/10.1097/jto.0b013e318074de34
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Clinical outcomes of a phase I/II study of 48 Gy of stereotactic body radiotherapy in 4 fractions for primary lung cancer using a stereotactic body frameInternational Journal of Radiation Oncology*Biology*Physics, 2005
- Stereotactic body radiation therapy of early-stage non–small-cell lung carcinoma: Phase I studyInternational Journal of Radiation Oncology*Biology*Physics, 2005
- Stereotactic hypofractionated high‐dose irradiation for stage I nonsmall cell lung carcinomaCancer, 2004
- Small-volume image-guided radiotherapy using hypofractionated, coplanar, and noncoplanar multiple fields for patients with inoperable Stage I nonsmall cell lung carcinomasCancer, 2002
- Lung Cancer in Japan: Analysis of Lung Cancer Registry for Resected Cases in 1994.Haigan, 2002
- A new approach to dose escalation in non–small-cell lung cancerInternational Journal of Radiation Oncology*Biology*Physics, 2001
- Involved-field radiotherapy alone for early-stage non–small-cell lung cancerInternational Journal of Radiation Oncology*Biology*Physics, 2000
- New Guidelines to Evaluate the Response to Treatment in Solid TumorsJNCI Journal of the National Cancer Institute, 2000
- Radiotherapy for patients with medically inoperable stage I nonsmall cell lung carcinomaCancer, 1998
- Prognostic factors in the treatment of node-negative nonsmall cell lung carcinoma with radiotherapy aloneInternational Journal of Radiation Oncology*Biology*Physics, 1996